Method of using interferon-like potein ZCYTO20 (IL-28A) or...

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S085400, C514S012200, C530S351000, C530S402000

Reexamination Certificate

active

07829076

ABSTRACT:
The present invention relates to polynucleotide and polypeptide molecules for zcyto20, zcyto21, zcyto22, zycto24, and zcyto25 proteins which are most closely related to interferon-α at the amino acid sequence level. The receptor for this protein family is a class II cytokine receptor. The present invention includes methods of reducing viral infections and increasing monocyte counts. The present invention also includes antibodies to the zcyto20 polypeptides, and methods of producing the polynucleotides and polypeptides.

REFERENCES:
patent: 6927040 (2005-08-01), Sheppard et al.
patent: 7135170 (2006-11-01), Klucher et al.
patent: 2008/0081786 (2008-04-01), Sheppard et al.
patent: 2008/0279816 (2008-11-01), Brady et al.
patent: 2009/0069274 (2009-03-01), Sheppard et al.
patent: 0 032 134 (1981-07-01), None
patent: 00/55324 (2000-09-01), None
patent: WO02/20569 (2002-03-01), None
patent: WO02/092762 (2002-11-01), None
patent: 03/066002 (2003-08-01), None
University Calif. Santa Cruz Genome Browser Database—Aug. 6, 2001, Accession No. C19001210.
University Calif. Santa Cruz Genome Browser Database—Aug. 6, 2001, Accession No. C19001212.
University Calif. Santa Cruz Genome Browser Database—Aug. 6, 2001, Accession No. C19001213.
University Calif. Santa Cruz Genome Browser Database—Dec. 22, 2001, Accession No. C19001260.
University Calif. Santa Cruz Genome Browser Database—Dec. 22, 2001, Accession No. C19001256.
University Calif. Santa Cruz Genome Browser Database—Dec. 22, 2001, Accession No. C19001257.
Ensembl Contig. View Sanger Institute—Apr. 19, 2001, Accession No. AC011445.
Ensembl Contig. View Sanger Institute—Apr. 18, 2000, Accession No. AC018477.
Universitry Calif. Santa Cruz Genome Browser—Chromosome 19, Apr. 20, 2001.
Adams et al., “3,400 expressed sequence tags identify diversity of transcripts from human brain,”Nat. Genet. 4:256-267 (1993).
GenBank Submission XP-002202436, Oct. 12, 2000.
GenBank Submission XP-002202437, Dec. 12, 1999.
Sheppard et al., “IL-28, IL-29 and their class II cytokine receptor IL-28R,”Nature Immun. 4(1):63-68, 2002.
Kotenko et al., “IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex,”Nature Immun. 4(1):69-77, 2002.
Kindsvogel et al., “Novel Interferon-Like Cytokines not Recognized by the Type I Interferon Receptor,”J. Interferon Cytokine Res. 22(1):S-48, 2002.
Brack et al., “Molecular Analysis of the Human Interferon-Alpha Gene Family,”Gene 15:379-394, 1981.
Xie et al., “Interleukin (IL)-22, a Novel Human Cytokine That Signals through the Interferon Receptor-related Proteins CRF2-4 and IL-22R,”J. Biol. Chem. 275(40):31335-31339, 2000.
Database Embl Sequence Library EBI. Hinxton—Oct. 8, 1999, Accession No. AC011445.
Vilcek, “Novel interferons,”Nature Immunology 4(1):8-9, 2003.
Burge et al., “Prediction of Complete Gene Structures in Human Genomic DNA,”J. Mol. Biol. 268:78-94, 1997.
Sheppard, U.S. Appl. No. 12/352,454, filed Jan. 12, 2009.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method of using interferon-like potein ZCYTO20 (IL-28A) or... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of using interferon-like potein ZCYTO20 (IL-28A) or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of using interferon-like potein ZCYTO20 (IL-28A) or... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4231215

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.